In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
about
Migraine Triggers and Oxidative Stress: A Narrative Review and SynthesisHigh-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats.Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in ratsInteraction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamineSelective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.A previous potassium stimulation enhances the increases of striatal extracellular dopamine and 5-hydroxytryptamine during global ischaemia under simulated penumbral conditions.Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
P2860
Q26774228-8E11F4B4-94DD-499B-A38F-88101BEB1FC2Q33557483-2F2C7019-C21B-4ED9-8096-32C4E41D4CA2Q35828300-B1651062-5762-4EF0-8DE9-16F173D3D633Q41596972-F7213DB5-BCD9-41F2-9170-4E0D83C52876Q42025081-2E97AB5C-6FE0-4AAB-BA74-F0A173BC3D0BQ42192457-4394192C-0671-451B-A6A9-FA8F831D82B9Q42475224-87F8E994-15C9-4779-A4D5-6AEDFC0FEB2DQ42481642-1597C84C-F32A-4AEF-BA61-15497CAAB1B4Q46690279-D42DCEBC-6808-4F5C-A60A-E8611B8F794D
P2860
In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
In vivo mechanisms underlying ...... using potassium and tyramine.
@en
In vivo mechanisms underlying ...... using potassium and tyramine.
@nl
type
label
In vivo mechanisms underlying ...... using potassium and tyramine.
@en
In vivo mechanisms underlying ...... using potassium and tyramine.
@nl
prefLabel
In vivo mechanisms underlying ...... using potassium and tyramine.
@en
In vivo mechanisms underlying ...... using potassium and tyramine.
@nl
P2093
P2860
P1476
In vivo mechanisms underlying ...... using potassium and tyramine.
@en
P2093
Butcher SP
Fairbrother IS
P2860
P304
P356
10.1111/J.1471-4159.1990.TB04881.X
P407
P577
1990-06-01T00:00:00Z